JANET BEEBE: Open Payments
NPI 1710981709 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 47 payments from 14 companies in 2025. Trend: 2023 $1,140 · 2024 $1,769 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 11 | $226 |
| ABBVIE INC. | 13 | $221 |
| PFIZER INC. | 4 | $99 |
| Indivior Inc. | 3 | $73 |
| Orexo US, Inc. | 4 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Lundbeck LLC | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $34 |
| Braeburn Inc. | 1 | $29 |
Products named: XTAMPZA, VRAYLAR, NURTEC ODT, SUBLOCADE, UBRELVY, Zubsolv, RELISTOR, CAPLYTA.
Industry payments across MD — which companies pay providers there.
